Treatment Response to Rehabilitation in Patients With Schizophrenia

NCT ID: NCT00063336

Last Updated: 2013-11-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2001-12-31

Study Completion Date

2005-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine the ways in which schizophrenia-related symptoms affect response to a rehabilitation program for people with schizophrenia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with schizophrenia often suffer neurocognitive impairment and psychosocial and vocational difficulties. This study will help identify those patients most likely to benefit from existing behavioral treatments and provide clues for how to modify treatments for those who do not benefit.

Two studies will be conducted. The first will investigate the relationship of symptoms and neurocognitive variables at study entry to psychosocial and vocational status 2 years later. The second study will investigate the relationship of symptoms and neurocognitive variables at study entry to treatment response in patients assigned to either a cognitive remediation track or a computer skills track as part of their rehabilitation treatment.

Both the cognitive remediation and computer skills training programs will last 4 to 6 months. Participants will be assessed pre- and post-treatment. Neuropsychological, psychosocial and vocational status will be measured.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Participants will receive cognitive remediation treatment.

Group Type EXPERIMENTAL

Cognitive Remediation

Intervention Type BEHAVIORAL

A computerized cognitive rehabilitation treatment with day-program activities

2

Participants will receive computer-skills training.

Group Type EXPERIMENTAL

Computer-skills training

Intervention Type BEHAVIORAL

A computerized cognitive rehabilitation treatment with day-program activities

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cognitive Remediation

A computerized cognitive rehabilitation treatment with day-program activities

Intervention Type BEHAVIORAL

Computer-skills training

A computerized cognitive rehabilitation treatment with day-program activities

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DSM-IV criteria for schizophrenia or schizoaffective disorder
* In need of intensive outpatient care
* Treatment with atypical antipsychotic medication for a minimum of 6 months prior to study entry

Exclusion Criteria

* Auditory or visual impairment
* Mental retardation (IQ less than 70)
* Traumatic brain injury with loss of consciousness
* Presence or history of any neurological illness that may affect brain physiology
* Lack of proficiency in English
* Concurrent substance abuse and/or dependence
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

Hartford Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Schizophrenia Rehabilitation Program, Institutes of Living

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthew M. Kurtz, PhD

Role: PRINCIPAL_INVESTIGATOR

Schizophrenia Rehabilitation Program, Institutes of Living

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Schizophrenia Rehabilitation Program, Institutes of Living

Hartford, Connecticut, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R03MH065377

Identifier Type: NIH

Identifier Source: secondary_id

View Link

DSIR AT-SP

Identifier Type: -

Identifier Source: secondary_id

R03MH065377

Identifier Type: NIH

Identifier Source: org_study_id

View Link